Read + Share
Oka H, Sumitomo S, Shimizu H, Ohmura K, et al. Markedly elevated serum IL-6 levels predict relapse within six months of
treatment initiation in Still's disease. Clin Exp Rheumatol 2024;42:2100-2101.
PMID: 39230746
|
 |
|
Oka H, Sumitomo S, Shimizu H, Ohmura K, et al. Markedly elevated serum IL-6 levels predict relapse within six months of
treatment initiation in Still's disease. Clin Exp Rheumatol 2024;42:2100-2101.
PMID: 39230746
|
|
|
|